ReShape Lifesciences Inc. (NASDAQ: RSLS) Stock Information | RedChip

ReShape Lifesciences Inc. (NASDAQ: RSLS)


$4.6600
-0.0600 ( +3.10% ) 4.5K

Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.

Market Data


Open


$4.6600

Previous close


$4.7200

Volume


4.5K

Market cap


$3.23M

Day range


$4.5100 - $4.7390

52 week range


$4.0900 - $29.0000

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Jan 16, 2024
pre Proxies and info statements 4 Jan 05, 2024

Latest News